The enhanced metastasis and invasion of ovarian cancer cells can be eliminated by blocking CCL2/CCR2 signaling transduction with CCL2 neutralizing antibodies or a CCL2 gene knockout defect [54]. The gene discussed is CCL2; the disease is ovarian carcinoma.